Table 2.
Characteristics | Odds ratios |
---|---|
| |
Race/ethnicity | |
Non-Hispanic White | Reference |
Non-Hispanic Black | 1.35 (1.11, 1.66) |
Hispanic | 1.05 (0.91, 1.21) |
Asian/Pacific Islander | 0.76 (0.63, 0.92) |
| |
Age (years) | |
12–24 | Reference |
25–29 | 0.62 (0.23, 1.67) |
30–34 | 0.79 (0.32, 1.98) |
35–39 | 1.23 (0.50, 3.01) |
40–44 | 0.96 (0.39, 2.34) |
45–50 | 0.42 (0.17, 1.04) |
| |
Year of diagnosis | |
1988–1994 | Reference |
1995–2001 | 3.47 (2.60, 4.62) |
2002–2008 | 5.34 (4.02, 7.09) |
2009–2014 | 6.56 (4.91, 8.75) |
| |
Tumor grade | |
Grade I | Reference |
Grade II | 1.29 (1.03, 1.60) |
Grade III | 1.76 (1.41, 2.21) |
Undifferentiated | 1.82 (1.22, 2.73) |
| |
Histology | |
Ductal | Reference |
Lobular | 1.16 (0.97, 1.40) |
| |
Tumor size | |
T1a: ≤0.5cm | Reference |
T1b: >0.5–1cm | 0.97 (0.76, 1.24) |
T1c: >1–2cm | 0.61 (0.49, 0.76) |
T2: >2–5cm | 0.43 (0.34, 0.55) |
T3: >5.00 cm | 0.38 (0.28, 0.52) |
Diffuse | 0.58 (0.34, 0.99) |
| |
Regional lymph node involvement | |
Positive | 0.58 (0.51, 0.67) |
Negative | Reference |
| |
ER and PR status | |
Positive | Reference |
Negative | 1.76 (1.52, 2.03) |
The estimates of odds ratios for unknown groups are not present.
Models adjusted for all variables in the table.
CI=confidence interval; ER=estrogen receptor; PR=progesterone receptor.